1-2 of 2
Alfonso D’Arco, M.D.
Close
Sort by
Journal Articles

A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens

Michele Cavo, MD, Antonio Palumbo, M.D., Sara Bringhen, M.D., Antonietta Falcone, M.D., Pellegrino Musto, M.D., Fabio Ciceri, M.D., Mariella Grasso, M.D., Renato Zambello, M.D., Maria Concetta Petti, M.D., Fabrizio Ciambelli, M.D., Giovanni De Sabbata, M.D., Stefano Rocco, M.D., Luigi Gugliotta, M.D., Filippo Gherlinzoni, M.D., Alfonso D’Arco, M.D., Massimo Martelli, M.D., Tommasina Guglielmelli, M.D., Paola Tacchetti, M.D., Michele Baccarani, M.D., Mario Boccadoro
Journal: Blood
Blood (2008) 112 (11): 3017.
https://doi.org/10.1182/blood.V112.11.3017.3017
Published: 2008
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008